CRP and type 2 diabetes mellitus: Several meta-analyses reported that GLP-1RAs reduced inflammatory biomarkers, such as C-reactive protein (CRP) and TNFα, and oxidative stress biomarkers, such as malondialdehyde, in subjects with type 2 diabetes [31,32].